Correlation Between Huaxia Fund and Shenzhen Bioeasy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Huaxia Fund and Shenzhen Bioeasy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Huaxia Fund and Shenzhen Bioeasy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Huaxia Fund Management and Shenzhen Bioeasy Biotechnology, you can compare the effects of market volatilities on Huaxia Fund and Shenzhen Bioeasy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Huaxia Fund with a short position of Shenzhen Bioeasy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Huaxia Fund and Shenzhen Bioeasy.

Diversification Opportunities for Huaxia Fund and Shenzhen Bioeasy

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Huaxia and Shenzhen is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Huaxia Fund Management and Shenzhen Bioeasy Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Bioeasy Bio and Huaxia Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Huaxia Fund Management are associated (or correlated) with Shenzhen Bioeasy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Bioeasy Bio has no effect on the direction of Huaxia Fund i.e., Huaxia Fund and Shenzhen Bioeasy go up and down completely randomly.

Pair Corralation between Huaxia Fund and Shenzhen Bioeasy

Assuming the 90 days trading horizon Huaxia Fund Management is expected to generate 0.43 times more return on investment than Shenzhen Bioeasy. However, Huaxia Fund Management is 2.34 times less risky than Shenzhen Bioeasy. It trades about 0.14 of its potential returns per unit of risk. Shenzhen Bioeasy Biotechnology is currently generating about 0.01 per unit of risk. If you would invest  283.00  in Huaxia Fund Management on December 26, 2024 and sell it today you would earn a total of  28.00  from holding Huaxia Fund Management or generate 9.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Huaxia Fund Management  vs.  Shenzhen Bioeasy Biotechnology

 Performance 
       Timeline  
Huaxia Fund Management 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Huaxia Fund Management are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Huaxia Fund may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Shenzhen Bioeasy Bio 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Shenzhen Bioeasy is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Huaxia Fund and Shenzhen Bioeasy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Huaxia Fund and Shenzhen Bioeasy

The main advantage of trading using opposite Huaxia Fund and Shenzhen Bioeasy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Huaxia Fund position performs unexpectedly, Shenzhen Bioeasy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will offset losses from the drop in Shenzhen Bioeasy's long position.
The idea behind Huaxia Fund Management and Shenzhen Bioeasy Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories